OLEA 106 - ACT | Breast
accelerating community trials | breast cancers
Status
ACT | Breast is actively recruiting the OLEA working group. The initiative anticipates finalize its scope in June 2023.
Click below to inquire about OLEA 106 - ACT | Breast.
Objectives
To improve clinical trial recruitment in community centers by supporting individuals through a digitized end to end clinical trial patient learning journey
To improve diversity metrics for breast cancer clinical trials
Digital Co-Creation
ACT | Breast will enhance the learn module to support the end to end clinical trial learning journey for breast cancer patients and their loved ones. Following deep listening sessions, patient and caregiver working group participants will co-create the digital experience on myRabble in an effort to improve community clinical trial recruitment rates in select cities.
WORKING GROUP:
OLEA 106 - ACT | Breast
-
Medical Lead - Open
partner with patient advocacy and alliance mgmt to oversee the conduct the development, implementation, and publications
-
Patient Lead - Open
local patient advocacy organization which partners with medical and alliance mgmt to oversee the conduct, development, implementation, and publications
-
Community Member - Open
partnering organization which extends community participation of the initiative to achieve sustainable benefit for the community as a whole
Join the effort
ABCD | Memphis is actively seeking sponsors and community partners to scale the initiative. Click below to inquire further.
